Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
139K
-
Shares change
-
-23.2K
-
Total reported value, excl. options
-
$538K
-
Value change
-
-$423K
-
Number of buys
-
3
-
Number of sells
-
-5
-
Price
-
$3.88
Significant Holders of Arcadia Biosciences, Inc. - COM (RKDA) as of Q2 2023
14 filings reported holding RKDA - Arcadia Biosciences, Inc. - COM as of Q2 2023.
Arcadia Biosciences, Inc. - COM (RKDA) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 139K shares
.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (118K shares), STATE STREET CORP (12.1K shares), UBS Group AG (5.01K shares), Tower Research Capital LLC (TRC) (2.93K shares), MORGAN STANLEY (213 shares), GROUP ONE TRADING, L.P. (104 shares), BlackRock Inc. (38 shares), WELLS FARGO & COMPANY/MN (6 shares), US BANCORP \DE\ (5 shares), and OLIVER LAGORE VANVALIN INVESTMENT GROUP (4 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.